# Dhampur Bio Organics share price today (Dhampur Bio Organics Ltd, NSE: DBOL)

> Dhampur Bio Organics share price today: ₹124.86 at the NSE close on 3 November 2026, up 58.1% in a year. Dhampur Bio Organics (NSE: DBOL) is worth ₹831 crore, trades at a P/E of 32.5 and has closed between ₹70.53 and ₹141.33 over the past 52 weeks. > Dhampur Bio Organics Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. DBOL · Sugar · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/dhampur-bio-organics-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Turning around, from the last 12 quarters
- Price: ₹124.86 (+58.1% in a year)
- P/E: 32.5× (higher than 78% of the last 4.1 years)
- Revenue (Jun 2026): ₹533 Cr (+8.3% on a year ago)
- Profit (Jun 2026): ₹37.0 Cr
- Operating margin: 1.7% (−0.1 points on a year ago)
- ROCE: 5%, FY26
- ROIC: 2.2%, against a 12.0% cost of capital: −9.8 points

Biggest thing to watch: the P/E is higher than 78% of its own history, so the multiple has already done part of the work. ## What is the Dhampur Bio Organics share price today? Dhampur Bio Organics Ltd's share price was ₹124.86 at the close on 3 November 2026. It has been rising for 38 weeks. That is 10.7% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹71 and ₹141, and at that close it sat 77% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 14 weeks in a row. Over the last 4.2 years the share price moved −24% while the NIFTY 500 moved +40%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Dhampur Bio Organics this quarter? One change stood out: profit up on a year earlier for 4 quarters in a row. 1. Profit up on a year earlier for 4 quarters in a row In the June 2026 quarter profit was ₹37 crore, +268.2% on a year earlier. ## What are Dhampur Bio Organics' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Dhampur Bio Organics reported revenue of ₹533 crore, up 8.3% from ₹492 crore a year earlier, and a profit of ₹37.0 crore, against a loss of ₹22.0 crore a year earlier. ### Dhampur Bio Organics results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹533 crore | ₹492 crore | +8.3% |
| Profit | ₹37.0 crore | loss of ₹22.0 crore | n/a |
| Earnings per share | ₹5.54 | ₹−3.31 | n/a |
| Operating margin | 1.7% | 1.8% | −0.1 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Dhampur Bio Organics share price history? Dhampur Bio Organics closed at ₹124.86 on 3 November 2026, up 58.1% from ₹78.96 a year earlier (31 October 2025) and down 21.8% over three years. Its highest weekly close since September 2022 was ₹210.10 on 2 December 2022. ### Dhampur Bio Organics share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹123.33 | +1.2% |
| 1 month ago · 1 Oct 2026 | ₹120.91 | +3.3% |
| 6 months ago · 30 Apr 2026 | ₹125.08 | −0.2% |
| 1 year ago · 31 Oct 2025 | ₹78.96 | +58.1% |
| 3 years ago · 3 Nov 2023 | ₹159.60 | −21.8% |
| Earliest weekly close in our records · 9 Sep 2022 | ₹164.95 | −24.3% |
| Highest weekly close since September 2022 · 2 Dec 2022 | ₹210.10 | −40.6% |
| Lowest weekly close since September 2022 · 13 Mar 2025 | ₹60.36 | +106.9% |
| 52-week high (weekly close) · 9 Oct 2026 | ₹141.33 | −11.7% |
| 52-week low (weekly close) · 14 Nov 2025 | ₹70.53 | +77.0% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (225 weekly closes from 9 September 2022 to 3 November 2026.)

## What is the latest news on Dhampur Bio Organics? 3 Nov 2026: Dhampur Bio Organics closed at ₹124.86, up 1.2% on the week and up 3.3% on the month. 17 Jul 2026: ex-date for a dividend of ₹1.50 a share. ### Earlier

- Results for April to June 2026: Revenue up 8.3% on a year earlier. ## What dividend does Dhampur Bio Organics pay? Dhampur Bio Organics paid ₹1.50 a share in regular dividends in the 12 months to 4 November 2026 (1 payment), a yield of 1.20% at the ₹124.86 close on 3 November 2026. The last was a dividend of ₹1.50 a share, ex-date 17 July 2026. ### Dhampur Bio Organics dividends since 1 April 2021

| Ex-date | Dividend per share | Type |
| --- | --- | --- |
| 17 Jul 2026 | ₹1.50 | Dividend |
| 4 Jul 2025 | ₹1.25 | Dividend |
| 28 Jun 2024 | ₹2.50 | Dividend |
| 23 Jun 2023 | ₹3.50 | Dividend |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here. 3 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. Dhampur Bio Organics Ltd paid out 40% of its profit as dividends in FY26, and it paid a dividend in 4 of its last 6 reported years. (From the NSE corporate-actions record, read 4 November 2026.)

## Which stock lists is Dhampur Bio Organics on? Dhampur Bio Organics is on one of our India lists: Undervalued stocks. [Undervalued stocks Profit growth x: 2.9615384615384617](https://www.sectoralpha.in/markets/in/deep-value-stocks)

## Is Dhampur Bio Organics profitable? Dhampur Bio Organics Ltd earned ₹37.0 Cr of net profit in the Jun 2026 quarter. Full-year FY26 profit was ₹25.0 Cr. That is 6.9% of the quarter's revenue. The same quarter a year earlier lost ₹22.0 Cr. 5 of the last 12 reported quarters were loss-making. For the full year, FY26 profit was ₹25.0 Cr (+66.7% on the year before). ## How much revenue does Dhampur Bio Organics make, and is it growing? Dhampur Bio Organics Ltd reported ₹533 Cr of revenue in the Jun 2026 quarter, +8.3% on the same quarter a year earlier. The last full year, FY26, came in at ₹2,109 Cr. The last four reported quarters add to ₹2,037 Cr. A growth rate over several years is not shown, because there are too few years of figures to work one out properly. FY26 revenue was ₹2,109 Cr, +13.3% on the year before. Is growth speeding up? Revenue over the last 12 months grew +8.0%, against +8.0% a year over the last 8 quarters (stabilising). ## How much of every ₹100 of sales does Dhampur Bio Organics keep? Dhampur Bio Organics Ltd's operating margin was 1.7% in the Jun 2026 quarter, 0.1 percentage points lower than the same quarter a year ago. Across 5 years it has been between 6.0% and 12.0%. The latest quarter is below every full year in that period. Why the margin moved: operating margin changed −0.1 percentage points on the year while gross margin changed +2.6 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Dhampur Bio Organics' profit turning into cash? Over the last 3 years, 290% of Dhampur Bio Organics Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹220 Cr of operating cash against ₹25.0 Cr of profit. After ₹36.0 Cr of spending on assets, ₹184 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 290% of profit came in as cash: the cash cycle got 96 days shorter between FY22 and FY26, so cash that used to wait in the business now arrives sooner. What to look at next: the bigger use of cash is spending on new assets, at 2.2× depreciation over three years. The next section checks what that spending is building. ## Where does Dhampur Bio Organics' cash go? Dhampur Bio Organics Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 216 days in FY26, down from 312 days in FY22. It spent ₹349 Cr on assets over the last 3 years. Customers take 11 days to pay, and stock sits for 231 days on average. At FY26 sales of ₹2,109 Cr, each day of that cycle ties up about ₹5.8 Cr, so roughly ₹1,248 Cr is tied up in the business at any time. FY26: customers took 11 days to pay and stock sat for 231 days, about 7.6 months of sales sitting as stock, for a full cycle of 216 days, shorter than FY22's 312. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 231 days. Customers pay about 11 days after that. Suppliers are paid at 26 days. Together that makes the 216-day cycle. Spending on assets: ₹349 Cr over the last 3 years, against ₹162 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹1.0 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Dhampur Bio Organics' P/E ratio, and how does it compare with its own history? Dhampur Bio Organics Ltd's P/E is 32.5×, near the high end of its own history: higher than 78% of past readings. Its usual P/E (the middle reading) is 23.9×, over 4.1 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +71.5% while the price moved +58.1%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 3 years the price moved −7.9% a year; about −38.1% a year came from earnings growth and about +30.2 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Dhampur Bio Organics business getting better or worse? Dhampur Bio Organics Ltd's business is turning around. Profit growth has swung from −100.0% at its low to +66.7%, rising from a low 2 quarters ago, with ROCE steady at 12.1%. This is based on 12 quarters of 4 measures. Why it matters: a turn in growth is often where a bigger change starts. The lines say a turn is forming, so the question is whether the next quarters confirm it. ## What is Dhampur Bio Organics management's track record? MGMT fail, see Step 6 batch reports for detail. (Checked 4 March 2026.)

## How much does Dhampur Bio Organics earn on its capital? Dhampur Bio Organics Ltd earned a ROCE of 5% in FY26. That is up from a low of 4% in FY25. Its return on capital used (ROIC) is 9.8 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 1.2% net margin and 0.91× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 1.2% net margin × 0.91× asset turnover × 2.26× leverage (assets divided by equity) ≈ 2.5% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 2.2% − 12.0% = −9.8 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Dhampur Bio Organics have too much debt? Dhampur Bio Organics Ltd has total debt of ₹1,060 Cr against shareholder equity of ₹1,027 Cr as of Jun 2026, so its debt is 1.03× its equity. Year by year, that ratio went from 0.95 in FY22 to 1.03 in FY26. Keep that borrowing in mind when reading the returns on this page. ## What is the Dhampur Bio Organics shareholding pattern? Domestic institutions cut their stake in Dhampur Bio Organics Ltd by 1.0 percentage points over 8 quarters, the biggest change among its owners. Domestic institutions now own 0.4% of the company. Foreign institutions moved −0.3 points over the same period, to 0.6%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Domestic institutions: −1.0 points over 8 quarters, to 0.4%; Foreign institutions: −0.3 points over 8 quarters, to 0.6%; Promoters: +0.2 points over 8 quarters, to 51.0%. Why the owners changed: domestic institutions drove it (−1.0 points). They reduced their stake. ## How far is Dhampur Bio Organics from balance-sheet trouble? For Dhampur Bio Organics Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Dhampur Bio Organics rank in its industry? 56.2 out of 100, rank 4 of 21 in Sugar, with 78% of the evidence available. Dhampur Bio Organics Ltd scores 56.2 out of 100 against the 21 companies it is compared with in Sugar, ranking 4. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 21 + 7.7 + 10.3 + 17.2 = 56.2. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Dhampur Bio Organics compared with? Dhampur Bio Organics ranks 4 of 21 Sugar companies on the 4-Factor Sector Score, with 56.2 out of 100. 1. [Andhra Sugars Ltd](https://www.sectoralpha.in/stocks/andhra-sugars-ltd) ANDHRSUGAR · losing its lead · Most evidence points up · 96% evidence 65.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 29.8/35 · Revenue 16.5% · Profit 100% · Operating margin change 3 points · 88% evidence Capital efficiency 13.8/25 · ROCE 8.4% · Operating margin 12% · 100% evidence Valuation 15.7/20 · P/E 9.1× · PEG 0.68 · 100% evidence Relative strength 6.1/20 · Lead over its industry -3% · Lead over NIFTY 500 -0.5% · 1 year -3.3% · 100% evidence · 10 of 12 weeks ahead Exact sum: 29.8 + 13.8 + 15.7 + 6.1 = 65.4 · What this means: Earnings are strong; relative strength in its sector is -3% and the one-year return is -3.3%. 2. [Dhampur Sugar Mills Ltd](https://www.sectoralpha.in/stocks/dhampur-sugar-mills-ltd) DHAMPURSUG · breaking out · Evidence leans up · 96% evidence 61.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.3/35 · Revenue 1.3% · Profit 36.3% · Operating margin change 1.3 points · 88% evidence Capital efficiency 9.6/25 · ROCE 6.4% · Operating margin 5.7% · 100% evidence Valuation 11.9/20 · P/E 14.6× · PEG 0.51 · 100% evidence Relative strength 18.8/20 · Lead over its industry 15.4% · Lead over NIFTY 500 17.9% · 1 year 16.7% · 100% evidence · 12 of 12 weeks ahead Exact sum: 21.3 + 9.6 + 11.9 + 18.8 = 61.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [DCM Shriram Ltd](https://www.sectoralpha.in/stocks/dcm-shriram-ltd) DCMSHRIRAM · quiet · Evidence leans up · 100% evidence 57.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.4/35 · Revenue 13.8% · Profit 93.7% · Operating margin change -2 points · 100% evidence Capital efficiency 15.4/25 · ROCE 11.5% · Operating margin 7% · 100% evidence Valuation 18.1/20 · P/E 10.4× · PEG 0.44 · 100% evidence Relative strength 2.3/20 · Lead over its industry -18.9% · Lead over NIFTY 500 -16.1% · 1 year -31.8% · 100% evidence · 0 of 12 weeks ahead Exact sum: 21.4 + 15.4 + 18.1 + 2.3 = 57.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. Dhampur Bio Organics Ltd this page DBOL · breaking out · Evidence leans up · 78% evidence 56.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.0/35 · Revenue 8% · Profit 100% · Operating margin change -0.1 points · 65% evidence Capital efficiency 7.7/25 · ROCE 5% · Operating margin 1.7% · 100% evidence Valuation 10.3/20 · P/E 30.5× · PEG n/a · 50% evidence Relative strength 17.2/20 · Lead over its industry 14% · Lead over NIFTY 500 16.4% · 1 year 48.7% · 100% evidence · 9 of 12 weeks ahead Exact sum: 21 + 7.7 + 10.3 + 17.2 = 56.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [EID Parry (India) Ltd](https://www.sectoralpha.in/stocks/eid-parry-indialtd) EIDPARRY · quiet · Evidence leans up · 63% evidence 54.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.8/35 · Revenue 15.7% · Profit -38.9% · Operating margin change -1 points · 83% evidence Capital efficiency 17.9/25 · ROCE 17% · Operating margin 8% · 76% evidence Valuation 11.9/20 · P/E 13.2× · PEG n/a · 50% evidence Relative strength 7.9/20 · Lead over its industry n/a · Lead over NIFTY 500 -23.7% · 1 year -44% · 25% evidence · 2 of 12 weeks ahead Exact sum: 16.8 + 17.9 + 11.9 + 7.9 = 54.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [M.V.K. Agro Food Product Ltd](https://www.sectoralpha.in/stocks/mvk-agro-food-product-ltd) MVKAGRO · basing · Evidence leans up · 64% evidence 54.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.5/35 · Revenue 127.3% · Profit 267.2% · Operating margin change -7.5 points · 88% evidence Capital efficiency 16.8/25 · ROCE 14.4% · Operating margin 10.8% · 100% evidence Valuation 9.6/20 · P/E 23.4× · PEG n/a · 15% evidence Relative strength 7.5/20 · Lead over its industry n/a · Lead over NIFTY 500 -48.8% · 1 year -56.2% · 25% evidence · 0 of 12 weeks ahead Exact sum: 20.5 + 16.8 + 9.6 + 7.5 = 54.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Ugar Sugar Works Ltd](https://www.sectoralpha.in/stocks/ugar-sugar-works-ltd) UGARSUGAR · breaking out · Evidence leans up · 76% evidence 52.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.0/35 · Revenue -0.7% · Profit 100% · Operating margin change -0.7 points · 74% evidence Capital efficiency 11.0/25 · ROCE 9% · Operating margin -2.9% · 100% evidence Valuation 12.6/20 · P/E 16.7× · PEG 0.77 · 100% evidence Relative strength 10.0/20 · Lead over its industry n/a · Lead over NIFTY 500 -0.2% · 1 year n/a · 25% evidence · 6 of 6 weeks ahead Exact sum: 19 + 11 + 12.6 + 10 = 52.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [DCM Shriram Industries Ltd](https://www.sectoralpha.in/stocks/dcm-shriram-industries-ltd) DCMSRIND · Evidence leans up · 76% evidence 51.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.4/43.75 · Revenue -3.7% · Profit -50% · Operating margin change -7.8 points · 88% evidence Capital efficiency 19.8/31.25 · ROCE 13.7% · Operating margin 0.9% · 100% evidence Valuation 15.7/25 · P/E 8.2× · PEG 0.5 · 100% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 16.4 + 19.8 + 15.7 = 51.9 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone. 9. [Balrampur Chini Mills Ltd](https://www.sectoralpha.in/stocks/balrampur-chini-mills-ltd) BALRAMCHIN · leader · Evidence leans up · 96% evidence 51.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 15.5/35 · Revenue 15% · Profit -11.2% · Operating margin change -2 points · 88% evidence Capital efficiency 13.3/25 · ROCE 9.3% · Operating margin 7% · 100% evidence Valuation 9.6/20 · P/E 33.6× · PEG 0.46 · 100% evidence Relative strength 12.8/20 · Lead over its industry 13% · Lead over NIFTY 500 15.4% · 1 year 28.4% · 100% evidence · 12 of 12 weeks ahead Exact sum: 15.5 + 13.3 + 9.6 + 12.8 = 51.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Triveni Engineering and Industries Ltd](https://www.sectoralpha.in/stocks/triveni-engineering-and-industries-ltd) TRIVENI · turning · Evidence leans up · 78% evidence 50.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.7/35 · Revenue 4% · Profit 29.1% · Operating margin change 1 points · 83% evidence Capital efficiency 12.2/25 · ROCE 9% · Operating margin 3.4% · 76% evidence Valuation 9.5/20 · P/E 19× · PEG n/a · 50% evidence Relative strength 8.3/20 · Lead over its industry -2.7% · Lead over NIFTY 500 0.1% · 1 year 4.8% · 100% evidence · 7 of 12 weeks ahead Exact sum: 20.7 + 12.2 + 9.5 + 8.3 = 50.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Dalmia Bharat Sugar & Industries Ltd](https://www.sectoralpha.in/stocks/dalmia-bharat-sugar-industries-ltd) DALMIASUG · leader · Evidence leans down · 96% evidence 49.6 out of 100 Growth Capital Valuation Relative
12. [Avadh Sugar & Energy Ltd](https://www.sectoralpha.in/stocks/avadh-sugar-energy-ltd) AVADHSUGAR · leader · Evidence leans down · 88% evidence 49.2 out of 100 Growth Capital Valuation Relative
13. [Uttam Sugar Mills Ltd](https://www.sectoralpha.in/stocks/uttam-sugar-mills-ltd) UTTAMSUGAR · breaking out · Evidence leans down · 68% evidence 47.2 out of 100 Growth Capital Valuation Relative
14. [Dwarikesh Sugar Industries Ltd](https://www.sectoralpha.in/stocks/dwarikesh-sugar-industries-ltd) DWARKESH · breaking out · Evidence leans down · 84% evidence 45.2 out of 100 Growth Capital Valuation Relative
15. [Magadh Sugar & Energy Ltd](https://www.sectoralpha.in/stocks/magadh-sugar-energy-ltd) MAGADSUGAR · breaking out · Evidence leans down · 88% evidence 38.8 out of 100 Growth Capital Valuation Relative
16. [Davangere Sugar Company Ltd](https://www.sectoralpha.in/stocks/davangere-sugar-company-ltd) DAVANGERE · Too little evidence to rank firmly · 59% evidence 38.5 out of 100 Growth Capital Valuation Relative
17. [Bajaj Hindusthan Sugar Ltd](https://www.sectoralpha.in/stocks/bajaj-hindusthan-sugar-ltd) BAJAJHIND · breaking out · Most evidence points down · 63% evidence 34.1 out of 100 Growth Capital Valuation Relative
18. [Shree Renuka Sugars Ltd](https://www.sectoralpha.in/stocks/shree-renuka-sugars-ltd) RENUKA · quiet · Most evidence points down · 71% evidence 33.4 out of 100 Growth Capital Valuation Relative
19. [Bannari Amman Sugars Ltd](https://www.sectoralpha.in/stocks/bannari-amman-sugars-ltd) BANARISUG · quiet · Most evidence points down · 96% evidence 29.7 out of 100 Growth Capital Valuation Relative
20. [Godavari Biorefineries Ltd](https://www.sectoralpha.in/stocks/godavari-biorefineries-ltd) GODAVARIB · quiet · Most evidence points down · 71% evidence 28.6 out of 100 Growth Capital Valuation Relative
21. [Zuari Industries Ltd](https://www.sectoralpha.in/stocks/zuari-industries-ltd) ZUARIIND · quiet · Too little evidence to rank firmly · 49% evidence 43.0 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Sugar](https://www.sectoralpha.in/sectors/sugar), all 21 compared on one page. ## Which companies are close to Dhampur Bio Organics in size? Dhampur Bio Organics is the 15th largest of 21 Sugar companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Andhra Sugars, Godavari Biorefineries and Dhampur Sugar Mills. Just below it: Dwarikesh Sugar Industries, Magadh Sugar & Energy and Zuari Industries. ### Sugar companies close in size

1. [Andhra Sugars Ltd](https://www.sectoralpha.in/stocks/andhra-sugars-ltd) ₹1,065 crore
2. [Godavari Biorefineries Ltd](https://www.sectoralpha.in/stocks/godavari-biorefineries-ltd) ₹1,044 crore
3. [Dhampur Sugar Mills Ltd](https://www.sectoralpha.in/stocks/dhampur-sugar-mills-ltd) ₹1,026 crore
4. Dhampur Bio Organics Ltd ₹779 crore
5. [Dwarikesh Sugar Industries Ltd](https://www.sectoralpha.in/stocks/dwarikesh-sugar-industries-ltd) ₹760 crore
6. [Magadh Sugar & Energy Ltd](https://www.sectoralpha.in/stocks/magadh-sugar-energy-ltd) ₹712 crore
7. [Zuari Industries Ltd](https://www.sectoralpha.in/stocks/zuari-industries-ltd) ₹705 crore

[All 21 Sugar companies, largest first](https://www.sectoralpha.in/sectors/sugar#all-companies)

### Companies close in size in other industries

1. [Vision Infra Equipment Solutions Ltd](https://www.sectoralpha.in/stocks/vision-infra-equipment-solutions-ltd) ₹782 crore · Trading
2. [Sudarshan Pharma Industries Ltd](https://www.sectoralpha.in/stocks/sudarshan-pharma-industries-ltd) ₹780 crore · Trading
3. Dhampur Bio Organics Ltd ₹779 crore
4. [Namo eWaste Management Ltd](https://www.sectoralpha.in/stocks/namo-ewaste-management-ltd) ₹778 crore · Recycling
5. [A B Infrabuild Ltd](https://www.sectoralpha.in/stocks/a-b-infrabuild-ltd) ₹777 crore · Construction - Civil/Turnkey

## What else do people ask about Dhampur Bio Organics? ### What is Dhampur Bio Organics's share price today? Dhampur Bio Organics Ltd's share price is ₹124.86, +58.1% over the past year. The whole company is worth ₹831 Cr on the market. In the last 52 weeks it traded between ₹71 to ₹141; today it is 77% of the way up from the low, 10.7% above its 200-day average (as of 3 November 2026). ### What were Dhampur Bio Organics's latest quarterly results? Dhampur Bio Organics Ltd reported revenue of ₹533 Cr and net profit of ₹37.0 Cr for the Jun 2026 quarter. Earnings per share were ₹5.54. The operating margin was 1.7%, 0.1 percentage points lower than a year earlier (as of 3 November 2026). ### What is Dhampur Bio Organics's market cap? Dhampur Bio Organics Ltd's market capitalisation is ₹831 Cr at a share price of ₹124.86. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Dhampur Bio Organics performing? Dhampur Bio Organics Ltd's share price has been rising for 38 weeks. Over the past 13 weeks it has done better than the NIFTY 500, for 14 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Dhampur Bio Organics's share price go up? This page does not forecast Dhampur Bio Organics Ltd's share price. What it shows instead: the share price is ₹124.86, and it has been rising for 38 weeks. Its P/E of 32.5× is higher than 78% of its own last 4 years (as of 3 November 2026). ### Where is Dhampur Bio Organics in its business cycle? Dhampur Bio Organics Ltd's FY26 operating margin was 6.0%, against a 5-year range of 6.0% to 12.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 1.7%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Dhampur Bio Organics story? Biggest thing to watch: the P/E is higher than 78% of its own history, so the multiple has already done part of the work. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Dhampur Bio Organics a stock worth studying right now? What the numbers show: Dhampur Bio Organics Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ## Lists

- Undervalued stocks: https://www.sectoralpha.in/markets/in/deep-value-stocks

This is research, not advice. We’re not SEBI-registered.